Fazio, Sergio

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice

Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 523

Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

Linton, M. F., Atkinson, J. B., & Fazio, S. (1995) · Science

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 478

Effects of Thyroid Hormone on the Cardiovascular System

Fazio, S. (2004) · Recent Progress in Hormone Research

Thyroid Disorders and TreatmentsCardiovascular Function and Risk Factors

Cited by 445

Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 439

Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages

Fazio, S., Babaev, V. R., Murray, A. B., Hasty, A. H., Carter, K. J., Gleaves, L. A., Atkinson, J. B., & Linton, M. F. (1997) · Proceedings of the National Academy of Sciences

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 295

Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency.

Merola, B., Cittadini, A., Colao, A., Longobardi, S., Fazio, S., Sabatini, D., Saccá, L., & Lombardi, G. (1993) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studies

Cited by 253

Mutations in the ANGPTL3 Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical Characterization

Minicocci, I., Montali, A., Robciuc, M. R., Quagliarini, F., Censi, V., Labbadia, G., Gabiati, C., Pigna, G., Sepe, M. L., Pannozzo, F., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 168

Deletion of Macrophage LDL Receptor–Related Protein Increases Atherogenesis in the Mouse

Overton, C. D., Yancey, P. G., Major, A. S., Linton, M. F., & Fazio, S. (2007) · Circulation Research

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 159

Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement

Cittadini, A., Cuocolo, A., Merola, B., Fazio, S., Sabatini, D., Nicolai, E., Colao, A., Longobardi, S., Lombardi, G., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism

Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studies

Cited by 154

The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy

Fazio, S., & Linton, M. F. (2004) · Current Atherosclerosis Reports

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 118

Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation

Hasty, A. H., Linton, M. F., Brandt, S. J., Babaev, V. R., Gleaves, L. A., & Fazio, S. (1999) · Circulation

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 105

Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor

Linton, M. F., Hasty, A. H., Babaev, V. R., & Fazio, S. (1998) · Journal of Clinical Investigation

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 100

The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia

Horie, Y., Fazio, S., Westerlund, J. R., Weisgraber, K. H., & Rall, S. C. (1992) · Journal of Biological Chemistry

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 94

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

Guyton, J. R., Brown, B. G., Fazio, S., Polis, A., Tomassini, J. E., & Tershakovec, A. M. (2008) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 91

Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice

Yamamoto, S., Zuo, Y., Ma, J., Yancey, P. G., Hunley, T. E., Motojima, M., Fogo, A. B., Linton, M. F., Fazio, S., Ichikawa, I., et al. (2011) · Nephrology Dialysis Transplantation

Atherosclerosis and Cardiovascular DiseasesDialysis and Renal Disease Management

Cited by 74

Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E

Fazio, S., Lee, Y. L., Ji, Z. S., & Rall, S. C. (1993) · Journal of Clinical Investigation

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 71

Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice

Fazio, S., Babaev, V. R., Burleigh, M. E., Major, A. S., Hasty, A. H., & Linton, M. F. (2002) · Journal of Lipid Research

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 58

Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies

Linton, M. F., & Fazio, S. (1999) · Current Opinion in Lipidology

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 51

Loss of Macrophage Low-Density Lipoprotein Receptor–Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition

Zhu, L., Giunzioni, I., Tavori, H., Covarrubias, R., Ding, L., Zhang, Y., Ormseth, M., Major, A. S., Stafford, J. M., Linton, M. F., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 46

Impaired secretion of apolipoprotein E2 from macrophages

Fan, D., Qiu, S., Overton, C. D., Yancey, P. G., Swift, L. L., Jerome, W. G., Linton, M. F., & Fazio, S. (2007) · Journal of Biological Chemistry

Cholesterol and Lipid MetabolismAlzheimer's disease research and treatments

Cited by 27

A prospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States

Lipworth, L., Fazio, S., Kabagambe, E., Munro, H., Nwazue, V., Tarone, R., McLaughlin, J., Blot, W., & Sampson, U. (2013) · Clinical Epidemiology

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 26

Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice

Yoshida, H., Hasty, A. H., Major, A. S., Ishiguro, H., Su, Y. R., Gleaves, L. A., Babaev, V. R., Linton, M. F., & Fazio, S. (2001) · Circulation

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 24

Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice

Tavori, H., Fan, D., Giunzioni, I., Zhu, L., Linton, M. F., Fogo, A. B., & Fazio, S. (2014) · Journal of Lipid Research

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 10